What Is Shaving Cream with Benzocaine
Shaving cream with benzocaine is a topical product that combines a lubricating shaving base with the local anesthetic benzocaine to numb the skin and reduce pain from razor cuts, nicks, and razor burn. Benzocaine is an ester-type local anesthetic that works by blocking sodium channels in nerve endings, temporarily preventing pain signals from reaching the brain. It is widely used in over-the-counter shaving gels, foams, and lotions marketed for sensitive skin, men, and women who experience irritation after shaving.
The global market for shaving products, including formulations with benzocaine, has grown steadily as consumers seek post-shave comfort and irritation relief. According to market research reports, the men's grooming segment alone is valued in the billions of dollars, with shaving creams and gels representing a significant share of product sales. Brands such as Edge, Skintimate, and Cremo have launched lines that highlight benzocaine as a key active ingredient for soothing the skin during and after shaving.
How Benzocaine Works in Shaving Cream
Mechanism of Action
Benzocaine works by reversibly binding to sodium channels on the neuronal cell membrane, inhibiting the influx of sodium ions and preventing the depolarization required for nerve impulse transmission. This results in a temporary loss of sensation in the applied area, which can reduce the discomfort associated with razor strokes, ingrown hairs, and minor skin abrasions. The onset of numbness typically occurs within minutes of application, and the effect can last for 15 to 30 minutes depending on the concentration and formulation.
Common Concentrations and Formulations
Over-the-counter shaving creams containing benzocaine typically use concentrations between 10% and 20% benzocaine. These products are available as gels, foams, creams, and aerosol sprays. Some formulations combine benzocaine with other soothing agents such as aloe vera, vitamin E, or menthol to enhance the cooling or moisturizing effect. The U.S. Food and Drug Administration regulates benzocaine products as over-the-counter topical anesthetics, and labeling must include warnings about potential allergic reactions and the risk of a rare but serious condition called methemoglobinemia, particularly in children under 2 years of age.
Safety, Risks, and Regulatory Status
The FDA has issued warnings about the use of benzocaine products in children under 2 years old due to the risk of methemoglobinemia, a condition in which the blood carries less oxygen than normal. Symptoms include pale, gray, or blue-colored skin, shortness of breath, fatigue, and confusion, and severe cases can be life-threatening. The FDA advises consumers to read labels carefully and to avoid using benzocaine-containing shaving products on children or infants unless directed by a healthcare professional. The agency continues to monitor adverse event reports related to benzocaine through its MedWatch program.
For adults, benzocaine in shaving creams is generally considered safe when used as directed, but some individuals may experience contact dermatitis, redness, or swelling. People with certain skin conditions, such as eczema or psoriasis, should consult a dermatologist before using products containing benzocaine. The Cosmetic Ingredient Review (CIR) panel has evaluated benzocaine and concluded that it is safe for use in cosmetic products at concentrations up to 20%, with appropriate labeling and warnings. Consumers can report adverse reactions to the FDA through the Safety Reporting Portal or by contacting the manufacturer directly. For more information on FDA guidance for over-the-counter topical anesthetics, visit the FDA website at https://www.fda.gov. Additional details on methemoglobinemia risks can be found in the FDA's drug safety communication at